Notification

No new Notification messages

Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
shukra pharmaceuticals limited stock

Shukra Pharmaceuticals Limited Share Price

- - (%)
- NSE: SHUKRAPHAR

Shukra Pharmaceuticals Limited Share Price Update

As of the latest trading session, Shukra Pharmaceuticals Limited share price is currently at 61.5, which is down by -2.27 from its previous closing. Today, the stock has fluctuated between 60.59 and 63.93. Over the past year, Shukra Pharmaceuticals Limited has achieved a return of 62.92 %. In the last month alone, the return has been -14.41 %. Read More...

Shukra Pharmaceuticals Limited Performance

Day Range

Low60.59 High63.93
61.50

52 Week Range

Low 20.43 High 129.90
61.50

Shukra Pharmaceuticals Limited Share Price

524632

SHUKRAPHAR

img img img img
No Data Available

Open Price

63.50

Prev. Close

63.77

Volume (Shares)

37562.00

Total traded value

23.10

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

Shukra Pharmaceuticals Limited Fundamentals


(Standalone)

Market Cap (Cr) 269.30
PE Ratio (TTM) 15.00
Book Value / Share 13.16
Beta 0.30
ROE 21.18%
EPS (TTM) 4.25
Dividend Yield 0.39%
Net Profit Qtr (Cr) 0.49

Shukra Pharmaceuticals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 3.18
Operating Expense 3.10
Net Profit 0.49
Net Profit Margin (%) 15.40
Earnings Per Share (EPS) 0.11
EBITDA 1.53
Effective Tax Rate (%) 38.74
Particulars MAR 2024 (Values in Cr)
Revenue 10.88
Operating Expense 7.04
Net Profit 3.99
Net Profit Margin (%) 36.67
Earnings Per Share (EPS) 3.64
EBITDA 5.81
Effective Tax Rate (%) 23.75
Particulars DEC 2023 (Values in Cr)
Revenue 18.89
Operating Expense 9.93
Net Profit 9.42
Net Profit Margin (%) 49.86
Earnings Per Share (EPS) 8.61
EBITDA 10.11
Effective Tax Rate (%) 1.15
Particulars SEP 2023 (Values in Cr)
Revenue 24.64
Operating Expense 20.16
Net Profit 4.71
Net Profit Margin (%) 19.11
Earnings Per Share (EPS) 1.47
EBITDA 5.32
Effective Tax Rate (%) -0.21
Particulars JUN 2023 (Values in Cr)
Revenue 20.16
Operating Expense 20.36
Net Profit 0.42
Net Profit Margin (%) 2.08
Earnings Per Share (EPS) 0.59
EBITDA 0.97
Effective Tax Rate (%) 2.32
Particulars MAR 2024 (Values in Cr)
Revenue 74.57
Operating Expense 57.51
Net Profit 18.54
Net Profit Margin (%) 24.86
Earnings Per Share (EPS) 16.93
EBITDA 22.22
Effective Tax Rate (%) 6.79
Particulars MAR 2023 (Values in Cr)
Revenue 58.83
Operating Expense 55.59
Net Profit 4.41
Net Profit Margin (%) 7.49
Earnings Per Share (EPS) 11.23
EBITDA 6.56
Effective Tax Rate (%) 0.90
Particulars MAR 2022 (Values in Cr)
Revenue 20.49
Operating Expense 19.55
Net Profit 0.75
Net Profit Margin (%) 3.66
Earnings Per Share (EPS) 4.79
EBITDA 2.96
Effective Tax Rate (%) 26.47
Particulars MAR 2021 (Values in Cr)
Revenue 11.20
Operating Expense 11.26
Net Profit 0.03
Net Profit Margin (%) 0.26
Earnings Per Share (EPS) 0.22
EBITDA 1.60
Effective Tax Rate (%) 60.00
Particulars MAR 2020 (Values in Cr)
Revenue 11.85
Operating Expense 11.78
Net Profit 0.04
Net Profit Margin (%) 0.33
Earnings Per Share (EPS) 0.23
EBITDA 1.65
Effective Tax Rate (%) 82.35
Particulars MAR 2023 (Values in Cr)
Book Value / Share 64.63
ROE % 21.18
ROCE % 18.84
Total Debt to Total Equity 0.20
EBITDA Margin 11.15
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.43
ROE % 4.69
ROCE % 5.81
Total Debt to Total Equity 0.41
EBITDA Margin 14.49
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.63
ROE % 0.90
ROCE % 1.35
Total Debt to Total Equity 0.57
EBITDA Margin 16.07
Particulars MAR 2020 (Values in Cr)
Book Value / Share 98.43
ROE % 0.13
ROCE % 0.36
Total Debt to Total Equity 0.46
EBITDA Margin 11.29
Particulars MAR 2019 (Values in Cr)
Book Value / Share 98.20
ROE % 3.03
ROCE % 3.60
Total Debt to Total Equity 0.32
EBITDA Margin 25.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.97
Total Assets 74.96
Total Liabilities 74.96
Total Equity 25.29
Share Outstanding 1565700
Price to Book Ratio 0.73
Return on Assets (%) 5.87
Return on Capital (%) 14.51
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.28
Total Assets 35.11
Total Liabilities 35.11
Total Equity 16.35
Share Outstanding 1565700
Price to Book Ratio 0.58
Return on Assets (%) 2.13
Return on Capital (%) 3.81
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.50
Total Assets 35.60
Total Liabilities 35.60
Total Equity 15.59
Share Outstanding 1565675
Price to Book Ratio 0.45
Return on Assets (%) 0.52
Return on Capital (%) 0.74
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 33.54
Total Liabilities 33.54
Total Equity 15.41
Share Outstanding 1565675
Price to Book Ratio 0.47
Return on Assets (%) 0.10
Return on Capital (%) 0.15
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.24
Total Assets 28.39
Total Liabilities 28.39
Total Equity 15.37
Share Outstanding 1565675
Price to Book Ratio 0.37
Return on Assets (%) 1.62
Return on Capital (%) 2.16
Particulars MAR 2023 (Values in Cr)
Net Income 4.44
Cash from Operations 3.41
Cash from Investing -4.42
Cash from Financing 4.94
Net change in Cash 3.68
Free Cash Flow 7.91
Particulars MAR 2022 (Values in Cr)
Net Income 1.01
Cash from Operations 8.42
Cash from Investing -1.52
Cash from Financing -6.67
Net change in Cash -0.21
Free Cash Flow 9.97
Particulars MAR 2021 (Values in Cr)
Net Income 0.09
Cash from Operations 0.53
Cash from Investing -1.89
Cash from Financing 1.73
Net change in Cash 0.37
Free Cash Flow 2.32
Particulars MAR 2020 (Values in Cr)
Net Income 0.17
Cash from Operations 1.23
Cash from Investing -3.11
Cash from Financing 1.99
Net change in Cash 0.12
Free Cash Flow 4.46
Particulars MAR 2019 (Values in Cr)
Net Income 0.72
Cash from Operations 0.40
Cash from Investing -2.45
Cash from Financing 2.37
Net change in Cash 0.18
Free Cash Flow 2.85
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.79 42.72 3.67 504.17 33.57 / 77.70
BLISS GVS PHARMA LTD 131.30 13.48 1.42 1378.20 77.65 / 148.95
CIPLA LTD 1628.10 29.58 4.92 131478.83 1132.00 / 1681.05
FERMENTA BIOTECH LIMITED 299.95 0.00 3.05 882.78 144.45 / 332.50
GLAXOSMITHKLINE PHARMA LT 2812.65 61.86 26.80 47647.99 1387.90 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.79 99.68 12.51 504.17 33.57 / 77.70
AMRUTAJAN HEALTH LTD 816.95 55.46 8.18 2361.85 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6896.90 131.62 24.21 17242.25 4050.15 / 7550.00
BLISS GVS PHARMA LTD 131.30 14.12 1.39 1378.20 77.65 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 64.70
  • 26 Days 69.30
  • 10 Days 64.70
  • 50 Days 80.00
  • 12 Days 64.80
  • 100 Days 84.30
  • 20 Days 66.90
  • 200 Days 32.90
63.81
PIVOT
First Resistance 65.61
Second Resistance 67.46
Third Resistance 69.26
First Support 61.96
Second Support 60.16
Third Support 58.31
RSI 52.37
MACD -4.58
Commodity Channel Index (CCI) -52.49
ADX 44.11
Williams % R -60.38

Over 1 Month

down

-14.41

Over 3 Months

down

-32.87

Over 6 Months

down

-27.56

Over 1 Year

down

62.92

Over 3 Years

down

155.35

Over 5 Years

down

99.06

Shukra Pharmaceuticals Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Shukra Pharmaceuticals Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
49.04
Promoter Holdings
50.95
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Yogesh Biharilal Parikh Public Shareholding 8400000.0 19.18
Renuka Yogesh Parikh Public Shareholding 8400000.0 19.18
Anar Project Private Limited Shareholding of Promoter and Promoter Group 8224000.0 18.78
Parshva Texchem India Private Ltd Shareholding of Promoter and Promoter Group 7517560.0 17.17
Navkar Surgical Gujarat Shareholding of Promoter and Promoter Group 5160000.0 11.78
Dakshesh Rameshchandra Shah Shareholding of Promoter and Promoter Group 436000.0 1.0
Anar Jayeshbhai Patel Shareholding of Promoter and Promoter Group 436000.0 1.0
Sujay Jyotindra Mehta Shareholding of Promoter and Promoter Group 312000.0 0.71
Payal Sujay Mehta Shareholding of Promoter and Promoter Group 228000.0 0.52

Shukra Pharmaceuticals Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-15 0.5 Final 2023-09-16 Equity shares 2022-09-22 0.5 Final 2022-09-22 Equity shares 2019-09-19 0.5 Final 2019-09-21 Equity shares 2018-08-31 0.5 Final 2018-09-04 Equity shares 2017-09-01 0.5 Final 2017-09-05 Equity shares
Ex-Date Ex-Bonus Ratio
2024-04-20 2024-04-19 3:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Shukra Pharmaceuticals Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Shukra Pharmaceuticals Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Shukra Pharmaceuticals Ltd?

Answer Field

The share price of Shukra Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 61.50.

What is the Market Cap of Shukra Pharmaceuticals Ltd?

Answer Field

The market cap of Shukra Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 2,69.30 Cr. as of now.

What is the 52 Week High and Low of Shukra Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Shukra Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 129.90 and ₹ 20.43.

How to Buy Shukra Pharmaceuticals Ltd share?

Answer Field

You can trade in Shukra Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Shukra Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 62.92%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4800 Cr MTF Book

icon-with-text
loader